Scarborough Advisors, LLC Genetic Technologies LTD Transaction History

Scarborough Advisors, LLC

  • $606 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 30, 2023
SELL
$0.7 - $0.93 $376,413 - $500,092
-537,734 Reduced 98.06%
10,638 $8,000
Q3 2023

Nov 07, 2023
BUY
$0.7 - $0.93 $376,413 - $500,092
537,734 Added 5054.84%
548,372 $416,000
Q1 2023

Sep 07, 2023
BUY
$0.86 - $1.82 $9,148 - $19,361
10,638 New
10,638 $12,000

About GENETIC TECHNOLOGIES LTD

GENE Quotes by TradingView
  • Ticker GENE
  • Exchange OTC
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 15,389,900
  • Market Cap $11.9M
  • Description
  • Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...
More about GENE
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email